Irving JA - Search Results

1

Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia.

Case M, Matheson E, Minto L, Hassan R, Harrison CJ, Bown N, Bailey S, Vormoor J, Hall AG, Irving JA. Case M, et al. Among authors: irving ja. Cancer Res. 2008 Aug 15;68(16):6803-9. doi: 10.1158/0008-5472.CAN-08-0101. Cancer Res. 2008. PMID: 18701506

2

A case of mature B-cell ALL with coexistence of t(1;19) and t(14;18) and expression of the E2A/PBX1 fusion gene.

Rowe D, Devaraj PE, Irving JA, Hogarth L, Hall AG, Turner GE. Rowe D, et al. Among authors: irving ja. Br J Haematol. 1996 Jul;94(1):133-5. doi: 10.1046/j.1365-2141.1996.d01-1754.x. Br J Haematol. 1996. PMID: 8757523

3

Population-based study of the pattern of molecular markers of minimal residual disease in childhood and adult acute lymphoblastic leukemia: an assessment of the practical difficulty of representative sampling for trial purposes. Northern Region Haematology Group.

Middleton PG, Norden J, Levett D, Levasseur M, Miller S, Irving JA, Wood A, Reid MM, Taylor PR, Proctor SJ. Middleton PG, et al. Among authors: irving ja. Med Pediatr Oncol. 2000 Feb;34(2):106-10. doi: 10.1002/(sici)1096-911x(200002)34:2<106::aid-mpo6>3.0.co;2-l. Med Pediatr Oncol. 2000. PMID: 10657870

4

New drugs, new drug resistance mechanisms.

Hall AG, Irving J. Hall AG, et al. Expert Rev Anticancer Ther. 2002 Jun;2(3):239-40. doi: 10.1586/14737140.2.3.239. Expert Rev Anticancer Ther. 2002. PMID: 12113037 No abstract available.

5

Mismatch repair defects as a cause of resistance to cytotoxic drugs.

Irving JA, Hall AG. Irving JA, et al. Expert Rev Anticancer Ther. 2001 Jun;1(1):149-58. doi: 10.1586/14737140.1.1.149. Expert Rev Anticancer Ther. 2001. PMID: 12113123 Review.

6

Molecular diagnostics: a healthcare perspective.

Hall AG, Coulthard SA, Irving JA. Hall AG, et al. Among authors: irving ja. Expert Rev Mol Diagn. 2003 Jan;3(1):13-6. doi: 10.1586/14737159.3.1.13. Expert Rev Mol Diagn. 2003. PMID: 12528360 Review.

7

Low prevalence of the N363S polymorphism of the glucocorticoid receptor in South Asians living in the United Kingdom.

Syed AA, Irving JA, Redfern CP, Hall AG, Unwin NC, White M, Bhopal RS, Alberti KG, Weaver JU. Syed AA, et al. Among authors: irving ja. J Clin Endocrinol Metab. 2004 Jan;89(1):232-5. doi: 10.1210/jc.2003-030995. J Clin Endocrinol Metab. 2004. PMID: 14715855

8

BRAF gene is not mutated in mismatch repair-proficient or -deficient plasma cell dyscrasias.

Velangi M, Matheson E, Taylor P, Jackson G, Hall AG, Irving JA. Velangi M, et al. Among authors: irving ja. Leukemia. 2004 Mar;18(3):658-9. doi: 10.1038/sj.leu.2403286. Leukemia. 2004. PMID: 14749708 No abstract available.

9

DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma.

Velangi MR, Matheson EC, Morgan GJ, Jackson GH, Taylor PR, Hall AG, Irving JA. Velangi MR, et al. Among authors: irving ja. Carcinogenesis. 2004 Oct;25(10):1795-803. doi: 10.1093/carcin/bgh187. Epub 2004 May 13. Carcinogenesis. 2004. PMID: 15142887

10

Use of denaturing HPLC for detection of mutations in the BCR-ABL kinase domain in patients resistant to Imatinib.

Irving JA, O'Brien S, Lennard AL, Minto L, Lin F, Hall AG. Irving JA, et al. Clin Chem. 2004 Jul;50(7):1233-7. doi: 10.1373/clinchem.2004.034801. Clin Chem. 2004. PMID: 15229152 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters